These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 28963709)
1. Predictors and Prognostic Implications of Perioperative Chemotherapy Completion in Gastric Cancer. Karagkounis G; Squires MH; Melis M; Poultsides GA; Worhunsky D; Jin LX; Fields RC; Spolverato G; Pawlik TM; Votanopoulos KI; Levine EA; Schmidt C; Bloomston M; Cho CS; Weber S; Masi A; Berman R; Pachter HL; Staley CA; Newman E; Maithel SK; Hatzaras I J Gastrointest Surg; 2017 Dec; 21(12):1984-1992. PubMed ID: 28963709 [TBL] [Abstract][Full Text] [Related]
2. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection]. Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920 [No Abstract] [Full Text] [Related]
3. Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. Smyth EC; Fassan M; Cunningham D; Allum WH; Okines AF; Lampis A; Hahne JC; Rugge M; Peckitt C; Nankivell M; Langley R; Ghidini M; Braconi C; Wotherspoon A; Grabsch HI; Valeri N J Clin Oncol; 2016 Aug; 34(23):2721-7. PubMed ID: 27298411 [TBL] [Abstract][Full Text] [Related]
4. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis. Ejaz A; Spolverato G; Kim Y; Squires MH; Poultsides G; Fields R; Bloomston M; Weber SM; Votanopoulos K; Worhunsky DJ; Swords D; Jin LX; Schmidt C; Acher AW; Saunders N; Cho CS; Herman JM; Maithel SK; Pawlik TM Ann Surg Oncol; 2014 Oct; 21(11):3412-21. PubMed ID: 24845728 [TBL] [Abstract][Full Text] [Related]
5. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy. Kim Y; Squires MH; Poultsides GA; Fields RC; Weber SM; Votanopoulos KI; Kooby DA; Worhunsky DJ; Jin LX; Hawkins WG; Acher AW; Cho CS; Saunders N; Levine EA; Schmidt CR; Maithel SK; Pawlik TM Surgery; 2017 Aug; 162(2):285-294. PubMed ID: 28578142 [TBL] [Abstract][Full Text] [Related]
6. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data]. Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769 [No Abstract] [Full Text] [Related]
7. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma. He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881 [TBL] [Abstract][Full Text] [Related]
8. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer]. Lu W; Zeng X; Li N; Liu H Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512 [TBL] [Abstract][Full Text] [Related]
9. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment]. Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922 [No Abstract] [Full Text] [Related]
10. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy. Badgwell B; Blum M; Estrella J; Chiang YJ; Das P; Matamoros A; Fournier K; Mansfield P; Ajani J J Am Coll Surg; 2015 Jul; 221(1):83-90. PubMed ID: 26002780 [TBL] [Abstract][Full Text] [Related]
11. The role of oxaliplatin in the adjuvant setting of different Lauren's type of gastric adenocarcinoma after D2 gastrectomy: a real-world study. Cheng X; Yu S; Wang Y; Cui Y; Li W; Yu Y; Tang C; Jiang H; Ji Y; Sun Y; Wang X; Shen Z; Liu F; Liu TS Gastric Cancer; 2019 May; 22(3):587-597. PubMed ID: 30426294 [TBL] [Abstract][Full Text] [Related]
12. A real-life analysis on the indications and prognostic relevance of perioperative chemotherapy in locally advanced resectable gastric adenocarcinoma. Pardo F; Osorio J; Miranda C; Castro S; Miró M; Luna A; Garsot E; Momblán D; Galofré G; Rodríguez-Santiago J; Pera M; Clin Transl Oncol; 2020 Aug; 22(8):1335-1344. PubMed ID: 31865605 [TBL] [Abstract][Full Text] [Related]
13. Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years. Liang YX; Deng JY; Guo HH; Ding XW; Wang XN; Wang BG; Zhang L; Liang H World J Gastroenterol; 2013 Oct; 19(39):6568-78. PubMed ID: 24151383 [TBL] [Abstract][Full Text] [Related]
14. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy. Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479 [TBL] [Abstract][Full Text] [Related]
15. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial. Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma]. Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357 [TBL] [Abstract][Full Text] [Related]
18. Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative. Squires MH; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Levine EA; Jin LX; Cho CS; Winslow ER; Russell MC; Staley CA; Maithel SK J Am Coll Surg; 2015 Sep; 221(3):767-77. PubMed ID: 26228017 [TBL] [Abstract][Full Text] [Related]
19. Timing of postoperative chemotherapy in patients undergoing perioperative chemotherapy and gastrectomy for gastric cancer. Brenkman HJF; van Putten M; Visser E; Verhoeven RHA; Nieuwenhuijzen GAP; Slingerland M; van Hillegersberg R; Lemmens VEPP; Ruurda JP Surg Oncol; 2018 Sep; 27(3):421-427. PubMed ID: 30217297 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study. Chen L; Zhang C; Yao Z; Cui M; Xing J; Yang H; Zhang N; Liu M; Xu K; Tan F; Li Y; Jiang B; Su X BMC Cancer; 2021 Aug; 21(1):974. PubMed ID: 34461860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]